December 23, 2022
RFA-DK-22-039 - Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The purpose of this notice is to extend RFA-DK-22-039 ,"Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)", and to allow resubmissions from either RFA-DK-20-022 or RFA-DK-22-039.
An additional Application Due Date has been added for this funding opportunity announcement (FOA).The Key Dates and Award Information Tables are updated accordingly:
Part 1. Overview Information
Key Dates
Current Key Dates:
| Posted Date | October 21, 2022 |
| Open Date (Earliest Submission Date) | February 15, 2023 |
| Letter of Intent Date(s) | February 15, 2023 |
| Application Due Date(s) | Not applicable |
| AIDS Due Date(s) | March 15, 2023 |
| Scientific Merit Review | July 2023 |
| Advisory Council Review | October 2023 |
| Earliest Start Date | December 2023 |
| Expiration Date | March 16, 2023 |
| Due Dates for E.O. 12372 | Not Applicable |
New Key Dates:
| Posted Date | October 21, 2022 |
| Open Date (Earliest Submission Date) | February 15, 2023 |
| Letter of Intent Date(s) | February 15, 2023 and October 15, 2023 |
| Application Due Date(s) | Not applicable |
| AIDS Due Date(s) | March 15, 2023 and November 15, 2023 |
| Scientific Merit Review | July 2023 and March 2024 |
| Advisory Council Review | October 2023 and May 2024 |
| Earliest Start Date | December 2023 and July 2024 |
| Expiration Date | November 16, 2023 |
| Due Dates for E.O. 12372 | Not Applicable |
Part 2. Full Text of Announcement
Section II. Award Information
Application Types Allowed
Currently Reads:
New
Resubmission
Resubmission applications are only allowed from RFA-DK-20-022
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
Revised to Read:
New
Resubmission only from RFA-DK-20-022 and RFA-DK-22-039.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
All other aspects of this FOA remain unchanged.
For Division of Digestive Diseases and Nutrition-related inquiries:
Peter J. Perrin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: [email protected]
For Division of Kidney, Urologic and Hematologic Diseases-related inquiries:
Deepak Nihalani, Ph.D.
Division of Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-6417
Email: [email protected]
For Division of Diabetes, Endocrinology and Metabolic Diseases-related inquiries:
Saul Malozowski, M.D, Ph.D., M.B.A.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-451-4683
Email: [email protected]
and Human Services (HHS)
